STXS Stereotaxis, Inc.
$0.97▼ -5.80%
Healthcare
Other
Volume 309.5K
Avg Volume (10D) 604.1K
Key Metrics & Fundamentals
Market Cap
$97.23M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.95 - 3.04
% vs 50 MA
-21.75%
% vs 200 MA
-43.84%
RSI-14
29.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.60
Free Cash Flow
-$3.74M
Gross Rev
$7.67M
Gross Profit
$4.49M
EBITDA
-$4.16M
COGS
$3.18M
Operating Exp
$9.05M
Operating Income
-$4.57M
EBIT
-$4.57M
Pretax Income
-$4.47M
Net Income
-$4.47M
EPS (Diluted)
-0.05
Price & Volume History
Loading chart…
Recent News
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
GlobeNewswire · Oct 22, 2026 8:04 AM ET
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
GlobeNewswire · Oct 20, 2026 7:40 AM ET
Global Electrophysiology Devices Market Size, Share, Growth, and Forecast 2026-2035 | Pulsed Field Ablation and 3D Mapping Fuel 12.40% CAGR to USD 30.16 Billion by 2035
GlobeNewswire · Oct 15, 2026 7:22 AM ET
ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters
Zacks · Oct 13, 2026 12:40 PM ET
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
GlobeNewswire · Sep 16, 2026 7:59 AM ET
Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition?
Zacks · Sep 14, 2026 2:45 PM ET
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
GlobeNewswire · Sep 3, 2026 7:56 AM ET
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 18, 2026 6:44 PM ET
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
Zacks · Aug 12, 2026 2:33 PM ET
Stereotaxis, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See STXS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.